Cargando…

Synthesis and evaluation of AKR1C inhibitory properties of A-ring halogenated oestrone derivatives

Enzymes AKR1C regulate the action of oestrogens, androgens, and progesterone at the pre-receptor level and are also associated with chemo-resistance. The activities of these oestrone halides were investigated on recombinant AKR1C enzymes. The oestrone halides with halogen atoms at both C-2 and C-4 p...

Descripción completa

Detalles Bibliográficos
Autores principales: Sinreih, Maša, Jójárt, Rebeka, Kele, Zoltán, Büdefeld, Tomaž, Paragi, Gábor, Mernyák, Erzsébet, Rižner, Tea Lanišnik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8266253/
https://www.ncbi.nlm.nih.gov/pubmed/34227437
http://dx.doi.org/10.1080/14756366.2021.1937142
_version_ 1783719906627289088
author Sinreih, Maša
Jójárt, Rebeka
Kele, Zoltán
Büdefeld, Tomaž
Paragi, Gábor
Mernyák, Erzsébet
Rižner, Tea Lanišnik
author_facet Sinreih, Maša
Jójárt, Rebeka
Kele, Zoltán
Büdefeld, Tomaž
Paragi, Gábor
Mernyák, Erzsébet
Rižner, Tea Lanišnik
author_sort Sinreih, Maša
collection PubMed
description Enzymes AKR1C regulate the action of oestrogens, androgens, and progesterone at the pre-receptor level and are also associated with chemo-resistance. The activities of these oestrone halides were investigated on recombinant AKR1C enzymes. The oestrone halides with halogen atoms at both C-2 and C-4 positions (13β-, 13α-methyl-17-keto halogen derivatives) were the most potent inhibitors of AKR1C1. The lowest IC(50) values were for the 13α-epimers 2_2I,4Br and 2_2I,4Cl (IC(50), 0.7 μM, 0.8 μM, respectively), both of which selectively inhibited the AKR1C1 isoform. The 13α-methyl-17-keto halogen derivatives 2_2Br and 2_4Cl were the most potent inhibitors of AKR1C2 (IC(50), 1.5 μM, 1.8 μM, respectively), with high selectivity for the AKR1C2 isoform. Compound 1_2Cl,4Cl showed the best AKR1C3 inhibition, and it also inhibited AKR1C1 (Ki: AKR1C1, 0.69 μM; AKR1C3, 1.43 μM). These data show that halogenated derivatives of oestrone represent a new class of potent and selective AKR1C inhibitors as lead compounds for further optimisations.
format Online
Article
Text
id pubmed-8266253
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-82662532021-07-19 Synthesis and evaluation of AKR1C inhibitory properties of A-ring halogenated oestrone derivatives Sinreih, Maša Jójárt, Rebeka Kele, Zoltán Büdefeld, Tomaž Paragi, Gábor Mernyák, Erzsébet Rižner, Tea Lanišnik J Enzyme Inhib Med Chem Research Paper Enzymes AKR1C regulate the action of oestrogens, androgens, and progesterone at the pre-receptor level and are also associated with chemo-resistance. The activities of these oestrone halides were investigated on recombinant AKR1C enzymes. The oestrone halides with halogen atoms at both C-2 and C-4 positions (13β-, 13α-methyl-17-keto halogen derivatives) were the most potent inhibitors of AKR1C1. The lowest IC(50) values were for the 13α-epimers 2_2I,4Br and 2_2I,4Cl (IC(50), 0.7 μM, 0.8 μM, respectively), both of which selectively inhibited the AKR1C1 isoform. The 13α-methyl-17-keto halogen derivatives 2_2Br and 2_4Cl were the most potent inhibitors of AKR1C2 (IC(50), 1.5 μM, 1.8 μM, respectively), with high selectivity for the AKR1C2 isoform. Compound 1_2Cl,4Cl showed the best AKR1C3 inhibition, and it also inhibited AKR1C1 (Ki: AKR1C1, 0.69 μM; AKR1C3, 1.43 μM). These data show that halogenated derivatives of oestrone represent a new class of potent and selective AKR1C inhibitors as lead compounds for further optimisations. Taylor & Francis 2021-07-06 /pmc/articles/PMC8266253/ /pubmed/34227437 http://dx.doi.org/10.1080/14756366.2021.1937142 Text en © 2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Paper
Sinreih, Maša
Jójárt, Rebeka
Kele, Zoltán
Büdefeld, Tomaž
Paragi, Gábor
Mernyák, Erzsébet
Rižner, Tea Lanišnik
Synthesis and evaluation of AKR1C inhibitory properties of A-ring halogenated oestrone derivatives
title Synthesis and evaluation of AKR1C inhibitory properties of A-ring halogenated oestrone derivatives
title_full Synthesis and evaluation of AKR1C inhibitory properties of A-ring halogenated oestrone derivatives
title_fullStr Synthesis and evaluation of AKR1C inhibitory properties of A-ring halogenated oestrone derivatives
title_full_unstemmed Synthesis and evaluation of AKR1C inhibitory properties of A-ring halogenated oestrone derivatives
title_short Synthesis and evaluation of AKR1C inhibitory properties of A-ring halogenated oestrone derivatives
title_sort synthesis and evaluation of akr1c inhibitory properties of a-ring halogenated oestrone derivatives
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8266253/
https://www.ncbi.nlm.nih.gov/pubmed/34227437
http://dx.doi.org/10.1080/14756366.2021.1937142
work_keys_str_mv AT sinreihmasa synthesisandevaluationofakr1cinhibitorypropertiesofaringhalogenatedoestronederivatives
AT jojartrebeka synthesisandevaluationofakr1cinhibitorypropertiesofaringhalogenatedoestronederivatives
AT kelezoltan synthesisandevaluationofakr1cinhibitorypropertiesofaringhalogenatedoestronederivatives
AT budefeldtomaz synthesisandevaluationofakr1cinhibitorypropertiesofaringhalogenatedoestronederivatives
AT paragigabor synthesisandevaluationofakr1cinhibitorypropertiesofaringhalogenatedoestronederivatives
AT mernyakerzsebet synthesisandevaluationofakr1cinhibitorypropertiesofaringhalogenatedoestronederivatives
AT riznertealanisnik synthesisandevaluationofakr1cinhibitorypropertiesofaringhalogenatedoestronederivatives